For the Inventor, By the Inventor

Enter inventor name

Menlo Park, CA, United States of America

Cheng Hu

USPTO Granted Patents = 17 (Patent Applications = 6)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 10.5

ph-index = 5

Forward Citations = 102(Granted Patents)

Location History:

Menlo Park, CA (US) (2009 - 2016)
San Mateo, CA (US) (2017 - 2020)

Company Filing History:

Chemocentryx, Inc.

Years Active: 2009-2020

Loading Chart...

Loading Chart...

Loading Chart...

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10709712 - Biaryl amide compounds as kinase inhibitors (2020-07-14),

2. 10245267 - Biaryl amide compounds as kinase inhibitors (2019-04-02),

3. 10160726 - Quinolone derivatives as antibacterials (2018-12-25),

4. 9694016 - Biaryl amide compounds as kinase inhibitors (2017-07-04),

5. 9409909 - N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides (2016-08-09),

6. 8835468 - N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamides (2014-09-16),

7. 8778951 - Heteroaryl compounds and their uses (2014-07-15),

8. 8546434 - Triazole compounds as KSP inhibitors (2013-10-01),

9. 8481579 - Triazolyl phenyl benzenesulfonamides (2013-07-09),

10. 8445518 - Triazolyl pyridyl benzenesulfonamides (2013-05-21),

11. 8415381 - Heteroaryl compounds and their uses (2013-04-09),

12. 8198309 - N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamides (2012-06-12),

13. 8153818 - Triazolyl phenyl benzenesulfonamides (2012-04-10),

14. 7776877 - N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides (2010-08-17),

15. 7718683 - Triazolyl phenyl benzenesulfonamides (2010-05-18),

Title: Cheng Hu: A Tech Pioneer Shaping the Future

Introduction: Cheng Hu, a relentless innovator based in Menlo Park, CA, is known for his passion for pushing the boundaries of technology. With 17 patents to his name, Cheng's work continues to inspire and shape the future of the tech industry.

Latest Patents: Cheng's latest patents include "Biaryl amide compounds as kinase inhibitors," which provide innovative compounds for the treatment of disorders associated with Raf kinase activity. These compounds not only showcase Cheng's expertise but also highlight his commitment to advancing therapeutic solutions.

Career Highlights: Cheng has made significant contributions to companies like Chemocentryx, Inc. and Novartis AG, where his innovative mindset and technical acumen have led to groundbreaking discoveries. His dedication to research and development has solidified his reputation as a true pioneer in the field.

Collaborations: Throughout his career, Cheng has collaborated with esteemed professionals such as Anita Melikian and Trevor T. Charvat. These collaborations have not only enriched his work but have also fostered a culture of innovation and knowledge-sharing within the industry.

Conclusion: Cheng Hu's relentless pursuit of innovation and his passion for pushing the boundaries of technology truly make him a standout figure in the tech industry. His patented inventions and collaborations reflect his commitment to advancing the field, inspiring future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…